ERBB2 and breast carcinoma: Although FOXO3 was not reported to be involved in cell cycle arrest, Tang et al. showed that the key gene is p27, and treatment with lapatinib triggers G1 cell cycle arrest through both transcriptional and post-translational mechanisms in Her2-overexpressing breast cancer cell lines [45].